Vitrovo, Inc.

Contributing to high-definition visualization of cellular activity and supporting research into neuronal and cardiac diseases and drug discovery TOKYO, June 2, 2025 /PRNewswire/ -- Sony Semiconductor Solutions Corporation (Sony), SCREEN Holdings Co., Ltd. (SCREEN), and VitroVo Inc. (VitroVo) today announced that they have jointly developed and will offer on a trial basis a microelectrode array (MEA) system powered by high-density CMOS-MEA*1 equipped with approximately 237,000 electrodes. Combining Sony's advanced sensing devices, SCREEN Group's cellular electrical activity measurement technology, and VitroVo's MEA-driven compound evaluation and data analysis knowledge, the MEA system makes it possible to measure and record high-density cell activity data, which was previously difficult, and to visualize cellular activity in high definition. This innovation is aimed to contribute primarily to neuronal and cardiac disease research and drug discovery. MEA System Hardware Application and User Interface Sensor chip of the CMOS-MEA developed by Sony Semiconductor Solutions